Variant report

Variant	nsv527719
Chromosome Location	chr6:109624937-109631609
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:282)
CpG islands
(count:0)
Chromatin interactive
region (count:19)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:282 , 50 per page) page: 1 2 3 4 5 6

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:109629205-109629638	K562	blood:	n/a	n/a
2	ARID3A	chr6:109625011-109626078	K562	blood:	n/a	n/a
3	ATF1	chr6:109625016-109626254	K562	blood:	n/a	n/a
4	ATF1	chr6:109629257-109629660	K562	blood:	n/a	n/a
5	ATF3	chr6:109629213-109629644	K562	blood:	n/a	n/a
6	ATF3	chr6:109625416-109625984	K562	blood:	n/a	n/a
7	BACH1	chr6:109625548-109626037	K562	blood:	n/a	n/a
8	BATF	chr6:109625581-109625829	GM12878	blood:	n/a	n/a
9	BATF	chr6:109625525-109625958	GM12878	blood:	n/a	n/a
10	BCLAF1	chr6:109625340-109626130	K562	blood:	n/a	n/a
11	BHLHE40	chr6:109629163-109629679	K562	blood:	n/a	n/a
12	BHLHE40	chr6:109625057-109626198	K562	blood:	n/a	n/a
13	CBX3	chr6:109624641-109626455	K562	blood:	n/a	n/a
14	CBX3	chr6:109629106-109629725	K562	blood:	n/a	n/a
15	CBX3	chr6:109625470-109626072	K562	blood:	n/a	n/a
16	CCNT2	chr6:109624959-109626164	K562	blood:	n/a	n/a
17	CCNT2	chr6:109629222-109629662	K562	blood:	n/a	n/a
18	CCNT2	chr6:109628101-109628353	K562	blood:	n/a	n/a
19	CEBPB	chr6:109629166-109629766	K562	blood:	n/a	n/a
20	CEBPB	chr6:109629323-109629684	Hela-S3	cervix:	n/a	n/a
21	CEBPB	chr6:109625511-109626011	K562	blood:	n/a	n/a
22	CEBPB	chr6:109625261-109626198	K562	blood:	n/a	n/a
23	CEBPB	chr6:109629265-109629677	K562	blood:	n/a	n/a
24	CEBPB	chr6:109625542-109625909	K562	blood:	n/a	n/a
25	CEBPD	chr6:109625422-109626203	K562	blood:	n/a	n/a
26	CEBPD	chr6:109629097-109629652	K562	blood:	n/a	n/a
27	CEBPD	chr6:109625005-109626303	K562	blood:	n/a	n/a
28	CEBPD	chr6:109629137-109629784	K562	blood:	n/a	n/a
29	CHD2	chr6:109625065-109626025	K562	blood:	n/a	n/a
30	CREB1	chr6:109625283-109626208	K562	blood:	n/a	n/a
31	CTCF	chr6:109629308-109629584	K562	blood:	n/a	n/a
32	CTCF	chr6:109630202-109630274	GM10248	blood:	n/a	n/a
33	CTCF	chr6:109631225-109631433	MCF-7	breast:	n/a	n/a
34	CTCF	chr6:109631302-109631342	MCF-7	breast:	n/a	n/a
35	CTCF	chr6:109631173-109631462	K562	blood:	n/a	chr6:109631204-109631213
36	CTCF	chr6:109625380-109625530	RPTEC	kidney:	n/a	n/a
37	CTCF	chr6:109631160-109631310	MCF-7	breast:	n/a	chr6:109631204-109631213
38	CTCF	chr6:109631200-109631350	HEK293	kidney:	n/a	chr6:109631204-109631213
39	CTCF	chr6:109625560-109625710	K562	blood:	n/a	n/a
40	CTCF	chr6:109625501-109626140	K562	blood:	n/a	n/a
41	CTCF	chr6:109631280-109631430	A549	lung:	n/a	n/a
42	CTCF	chr6:109631172-109631565	K562	blood:	n/a	chr6:109631204-109631213
43	CTCF	chr6:109631255-109631406	K562	blood:	n/a	n/a
44	CTCF	chr6:109631261-109631344	MCF-7	breast:	n/a	n/a
45	CTCF	chr6:109631182-109631531	MCF-7	breast:	n/a	chr6:109631204-109631213
46	CTCF	chr6:109631194-109631418	K562	blood:	n/a	chr6:109631204-109631213
47	CTCF	chr6:109631185-109631585	MCF-7	breast:	n/a	chr6:109631204-109631213
48	CTCF	chr6:109631220-109631370	MCF-7	breast:	n/a	n/a
49	CTCF	chr6:109625640-109625790	RPTEC	kidney:	n/a	n/a
50	CTCF	chr6:109631333-109631366	GM20000	blood:	n/a	n/a

No data

(count:19 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:109625539..109627045-chr6:109630480..109632036,2	K562	blood:
2	chr6:109627149..109629191-chr6:109643019..109645963,3	K562	blood:
3	chr6:109622184..109625668-chr6:109702158..109705094,3	MCF-7	breast:
4	chr6:109556933..109558499-chr6:109629340..109630936,2	K562	blood:
5	chr6:109625731..109626429-chr6:109704175..109704833,2	K562	blood:
6	chr6:109625539..109627045-chr6:109630480..109632036,2	K562	blood:
7	chr6:109623746..109625263-chr6:109628123..109630735,2	K562	blood:
8	chr6:109619154..109621765-chr6:109622186..109624973,2	MCF-7	breast:
9	chr6:109628891..109631970-chr6:109702157..109703919,3	K562	blood:
10	chr6:109624351..109631970-chr6:109702157..109706422,11	K562	blood:
11	chr6:109627945..109629933-chr6:109634086..109636945,2	MCF-7	breast:
12	chr6:109555640..109560553-chr6:109624000..109628580,4	K562	blood:
13	chr6:109626552..109629448-chr6:109691931..109694820,2	K562	blood:
14	chr6:109623091..109628183-chr6:109700606..109706462,9	K562	blood:
15	chr6:109630848..109632942-chr6:109701333..109705023,3	MCF-7	breast:
16	chr6:109624816..109627658-chr6:109659263..109661556,2	K562	blood:
17	chr6:109627149..109629191-chr6:109642784..109645963,3	K562	blood:
18	chr6:109508798..109509659-chr6:109630971..109631761,2	MCF-7	breast:
19	chr6:109631513..109637347-chr6:109638223..109642715,6	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-C6orf183-4	chr6:109630473-109630857	NONHSAT114392

No data

Variant related genes	Relation type
ENSG00000201023	TF binding region
CCDC162P	TF binding region
ENSG00000203799	chromatin interactions
ENSG00000135535	chromatin interactions
ENSG00000243587	chromatin interactions
ENSG00000201023	chromatin interactions
ENSG00000260273	chromatin interactions

Extended variants
information (count: 251 )
Associated
traits (count: 114 )

Variant overlapped rSNPs/rCNVs (count:251 , 50 per page) page: 1 2 3 4 5 6

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs9784763	chr6:109624937-109624938	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs549968254	chr6:109624945-109624946	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
3	rs13209277	chr6:109624963-109624964	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs535213786	chr6:109625001-109625002	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
5	rs116455351	chr6:109625017-109625018	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
6	rs571975084	chr6:109625052-109625053	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
7	rs528389246	chr6:109625061-109625062	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
8	rs192284973	chr6:109625079-109625080	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
9	rs545320012	chr6:109625111-109625112	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
10	rs557427290	chr6:109625119-109625120	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
11	rs137896118	chr6:109625239-109625240	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
12	rs1935032	chr6:109625241-109625242	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
13	rs530662612	chr6:109625278-109625279	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
14	rs112500038	chr6:109625286-109625287	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
15	rs563513647	chr6:109625339-109625340	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
16	rs573861638	chr6:109625344-109625345	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
17	rs370632527	chr6:109625380-109625381	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
18	rs376112078	chr6:109625410-109625411	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
19	rs562231143	chr6:109625519-109625520	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
20	rs1006081	chr6:109625550-109625551	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
21	rs189196751	chr6:109625571-109625572	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
22	rs564096224	chr6:109625590-109625591	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
23	rs533494296	chr6:109625591-109625592	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
24	rs193058853	chr6:109625592-109625593	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
25	rs143896733	chr6:109625643-109625644	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
26	rs569950763	chr6:109625645-109625646	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
27	rs536026957	chr6:109625674-109625675	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
28	rs71558365	chr6:109625678-109625679	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
29	rs549284047	chr6:109625680-109625681	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
30	rs565776042	chr6:109625718-109625719	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
31	rs185579979	chr6:109625745-109625746	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
32	rs112095176	chr6:109625758-109625759	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
33	rs386704739	chr6:109625796-109625797	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
34	rs1546722	chr6:109625797-109625798	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs537375095	chr6:109625830-109625831	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
36	rs76863671	chr6:109625847-109625848	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
37	rs116285345	chr6:109625848-109625849	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
38	rs538241497	chr6:109625872-109625873	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
39	rs1546723	chr6:109625879-109625880	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs142406027	chr6:109625925-109625926	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
41	rs150538048	chr6:109625933-109625934	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
42	rs541166650	chr6:109625981-109625982	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
43	rs77096693	chr6:109625994-109625995	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
44	rs537684529	chr6:109626004-109626005	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
45	rs142808936	chr6:109626024-109626025	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
46	rs373667111	chr6:109626028-109626029	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
47	rs543735311	chr6:109626043-109626044	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
48	rs200203032	chr6:109626067-109626068	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
49	rs114922119	chr6:109626104-109626105	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
50	rs138551337	chr6:109626124-109626125	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:114)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Autism	22495311	CNVD
Gastric cancer	17908304	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
T-cell lymphomas	19863542	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Ependymoma	16718352	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Prostate cancer	18632612	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Urothelial carcinoma	18382360	CNVD
Ovarian neoplasms	16753589	CNVD
Hepatocellular carcinoma	16750200	CNVD
Wilms tumour	21544195	CNVD
Leukemia	18688285	CNVD
Prostate cancer	19242612	CNVD
Glioma	21046410	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Zellweger syndrome	21572526	CNVD
Follicular lymphoma	20505157	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Lung adenocarcinoma	21935476	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Chondromyxoid Fibroma	20696777	CNVD
Cancer	21183584	CNVD
Developmental delay	19490664	CNVD
Non-muscle invasive bladder neoplasm	19445696	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Burkitt''s lymphoma	18698080	CNVD
Ovarian cancer	21720365	CNVD
Basal cell lymphoma	17170743	CNVD
Prostate cancer	16573809	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	21785460	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	16461572	CNVD
Neurocytoma	17123091	CNVD
Cancer	20164920	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21364760	CNVD
Myelofibrosis	22110671	CNVD
Chronic lymphocytic leukemia	17805327	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Autism	17483303	CNVD
Chordoma	21602918	CNVD
Kartagener syndrome	16639409	CNVD
abnormal development	18461090	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Systemic lupus erythematosus	19220326	CNVD
Cancer	17160897	CNVD
Autism	19546859	CNVD
Schizophrenia	19546859	CNVD
Tourette syndrome	19546859	CNVD
Acute lymphoblastic leukemia	17229543	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	17133270	CNVD
Follicular lymphoma	18703704	CNVD
Mental retardation	17621639	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:227 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:109619200-109625800	Weak transcription	Brain Angular Gyrus	brain
2	chr6:109619200-109626800	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
3	chr6:109619400-109625000	Weak transcription	ES-I3 Cell Line	embryonic stem cell
4	chr6:109619400-109629200	Weak transcription	Gastric	stomach
5	chr6:109619400-109638000	Weak transcription	HepG2	liver
6	chr6:109619600-109625200	Weak transcription	HUES6 Cell Line	embryonic stem cell
7	chr6:109619600-109625400	Enhancers	Stomach Smooth Muscle	stomach
8	chr6:109619600-109625600	Weak transcription	Lung	lung
9	chr6:109619600-109626000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
10	chr6:109620000-109625000	Weak transcription	Primary B cells from cord blood	blood
11	chr6:109621400-109629600	Enhancers	Primary hematopoietic stem cells	blood
12	chr6:109621600-109625200	Weak transcription	Spleen	Spleen
13	chr6:109621600-109625600	Weak transcription	Right Atrium	heart
14	chr6:109621600-109634000	Weak transcription	Fetal Muscle Trunk	muscle
15	chr6:109621800-109625000	Weak transcription	Monocytes-CD14+_RO01746	blood
16	chr6:109621800-109625200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
17	chr6:109622000-109625800	Enhancers	Primary hematopoietic stem cells short term culture	blood
18	chr6:109622400-109625200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
19	chr6:109622400-109626200	Enhancers	Placenta	Placenta
20	chr6:109623000-109625000	Weak transcription	Brain Substantia Nigra	brain
21	chr6:109623000-109625400	Weak transcription	Brain Inferior Temporal Lobe	brain
22	chr6:109623000-109625600	Weak transcription	Adipose Nuclei	Adipose
23	chr6:109623200-109625000	Weak transcription	Psoas Muscle	Psoas
24	chr6:109623200-109625400	Weak transcription	Brain Anterior Caudate	brain
25	chr6:109623200-109625800	Weak transcription	Brain Hippocampus Middle	brain
26	chr6:109623400-109625000	Weak transcription	Right Ventricle	heart
27	chr6:109623400-109625000	Weak transcription	Skeletal Muscle Male	skeletal muscle
28	chr6:109623400-109625000	Weak transcription	Small Intestine	intestine
29	chr6:109623400-109625200	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
30	chr6:109623400-109625200	Weak transcription	Colon Smooth Muscle	Colon
31	chr6:109623400-109625200	Weak transcription	Fetal Heart	heart
32	chr6:109623400-109625400	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
33	chr6:109623600-109625000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
34	chr6:109623600-109625000	Weak transcription	Left Ventricle	heart
35	chr6:109623600-109625000	Weak transcription	Skeletal Muscle Female	skeletal muscle
36	chr6:109623600-109625200	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
37	chr6:109623600-109625400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
38	chr6:109623600-109629400	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
39	chr6:109624000-109627000	Weak transcription	Pancreatic Islets	Pancreatic Islet
40	chr6:109624400-109626000	Enhancers	Hela-S3	cervix
41	chr6:109624400-109626400	Flanking Active TSS	K562	blood
42	chr6:109624400-109626600	Enhancers	Rectal Mucosa Donor 31	rectum
43	chr6:109624600-109625600	Enhancers	Aorta	Aorta
44	chr6:109624600-109626200	Enhancers	Sigmoid Colon	Sigmoid Colon
45	chr6:109624600-109626400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
46	chr6:109624600-109626400	Enhancers	Primary monocytes fromperipheralblood	blood
47	chr6:109624600-109626400	Enhancers	Pancreas	Pancrea
48	chr6:109624600-109626600	Enhancers	Fetal Intestine Large	intestine
49	chr6:109624600-109631000	Enhancers	Fetal Intestine Small	intestine
50	chr6:109624800-109625400	Enhancers	Rectal Mucosa Donor 29	rectum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links